Answers are grounded in this paper and cite their sources.
Non-small cell lung cancer (NSCLC) is characterised by its aggressiveness and poor prognosis. Early detection and accurate prediction of therapeutic responses remain critical for improving patient outcomes. In the present study, we investigated the potential of circulating microRNA (miRNA) as non-invasive biomarkers in patients with NSCLC.
No takes yet. Share an insight, caveat, or question.
Abdipourbozorgbaghi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: